These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12647610)

  • 1. The role of pharmacoeconomic modeling in depression management by a health plan.
    Watkins JB
    Manag Care Interface; 2003; Suppl B():22-6. PubMed ID: 12647610
    [No Abstract]   [Full Text] [Related]  

  • 2. Precipitating factors for pharmaceutical firms.
    McCarthy R
    State Health Care Am; 1997; ():39-43. PubMed ID: 10168083
    [No Abstract]   [Full Text] [Related]  

  • 3. A pharmacoeconomic evaluation of major depressive disorder.
    Casciano R
    Manag Care Interface; 2003; Suppl B():16-21. PubMed ID: 12647609
    [No Abstract]   [Full Text] [Related]  

  • 4. The economics of lipid management.
    Mullins CD
    Manag Care; 2001 Nov; 10(11 Suppl):17-8; discussion 19-24. PubMed ID: 11761626
    [No Abstract]   [Full Text] [Related]  

  • 5. Roundtable discussion: Part III--Hypertension management in health plans.
    Penna P; Cox E; Joseph T; Lehman L; Morrow T; Richter A; Sowers J; Tepper D
    Manag Care Interface; 2000; Suppl C():24-31. PubMed ID: 11183936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reframing the pharmaceutical manufacturer/health plan relationship in managed care.
    Studin I
    Manag Care; 2002 Feb; 11(2):46, 49-54. PubMed ID: 11904913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of pharmacoeconomic data in managed care: closing the credibility gap.
    Lewis BE
    Manag Care Interface; 1997 Nov; 10(11):99-103. PubMed ID: 10174761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness measures of major depressive disorder in pharmacoeconomic evaluations.
    Casciano R
    Manag Care Interface; 2003; Suppl B():14-5. PubMed ID: 12647608
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacoeconomics in managed care pharmacy.
    Penna P
    Manag Care Interface; 2001 Aug; 14(8):53-4. PubMed ID: 11517838
    [No Abstract]   [Full Text] [Related]  

  • 13. The focus on true value in the health care system.
    Giaquinta D
    Manag Care Interface; 2007 Apr; 20(4):40-1. PubMed ID: 17474329
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost not the primary factor driving drug coverage.
    Capitation Rates Data; 2000 May; 5(5):51-3. PubMed ID: 11066970
    [No Abstract]   [Full Text] [Related]  

  • 16. Escalating need for comparative analysis of drugs within a therapeutic class.
    Giaquinta D
    Manag Care Interface; 2003 Oct; 16(10):32-4. PubMed ID: 14606258
    [No Abstract]   [Full Text] [Related]  

  • 17. Cut pharmaceutical costs, but mind the legal dangers.
    Abood RR
    Manag Care; 1997 Aug; 6(8):47-8, 51-4. PubMed ID: 10170246
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacoeconomics: a managed care perspective.
    Clouse JC
    Top Hosp Pharm Manage; 1994 Jan; 13(4):54-9. PubMed ID: 10130684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of depression: the implications for managed care--roundtable discussion: Part 2.
    Arikian S; Casciano J; Kang-Cipolla L; Vodoor M; Grubin M; Clark D; Waugh W; Kelsey J; Osborn LW
    Manag Care Interface; 2000; Suppl B():19-25, 32. PubMed ID: 11183021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wholesaling in the managed care market.
    Toscano S
    Med Interface; 1995 Dec; 8(12):78-81. PubMed ID: 10153522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.